Whitney Remily has over 16 years of experience in all areas of patent law, including rendering clearance, infringement and validity opinions, conducting due diligence and patent landscape analyses, licensing, detailed statements and notice letters, counseling in pharmaceutical litigation arising under the Hatch-Waxman Act, preparing patent term extensions, and preparing and prosecuting patent applications.
Ms. Remily has significant experience with pharmaceuticals, having handled various patent matters relating to filings of Abbreviated New Drug Applications by generic drug manufacturers. In this context, she has handled over 500 opinion matters, including issues relating to FDA exclusivity, new chemical entities, importation of active ingredients, synthetic intermediates, polymorphs, approved and off-label indications, finished formulations/compositions and drug products.
In addition, she has substantial experience in other technical areas including organic and inorganic chemistry, agrichemicals, cosmetics, diagnostics, polymers, food products, nutritional supplements, cigarettes, fine chemicals and medical devices.
Ms. Remily has represented a wide range of life sciences clients, most recently Teva Pharmaceuticals, Cipla Limited, Actavis (formerly Watson) Pharmaceuticals, Boston Scientific, and Nippon Oil & Energy. She has also represented Eastman Chemical, L’Oreal, Philip Morris (Altria), Air Liquide, Honda, Nippon Steel, Universal Display, Intervet/Schering-Plough Animal Health, Siegfried USA, Lonza Group, Impax Pharmaceuticals, Schwarz Pharma, Mayne Pharma (now Hospira), Breckenridge Pharamceuticals, and Elan Pharmaceuticals.
Ms. Remily has lectured on topics relating to opinion writing, patent searching, patent prosecution strategies and patent requirements.
As a former organic chemist, Ms. Remily previously worked at Merck, where she was involved in the synthesis of pharmaceutical compounds, as well as combinatorial chemistry approaches for lead optimization and drug discovery. During her graduate studies in organic chemistry at the Johns Hopkins University, her research related to the synthesis of novel trioxane and artemisinin analogs as anti-malarial or chemotherapeutic agents. While obtaining her undergraduate degree from Cornell University, she worked as a research assistant in both the Chemistry Department and the Material Science and Engineering Department.
Ms. Remily is a member of the firm’s diversity committee, Federal Circuit committee, and associates committee.